Intarcia

FierceBiotech Names Intarcia Therapeutics as One of the “Fierce 15" Biotech Companies of 2007

Intarcia Therapeutics selected based on innovative Hepatitis C drug candidate and expanding therapeutics pipeline

Emeryville, CA – June 6, 2007 – Intarcia Therapeutics, Inc. announced today that it has been named to the annual FierceBiotech “Fierce 15” list, designating it as one of the top biotech companies of 2007...more>>

Kadmus Pharmaceuticals

KADMUS PHARMACEUTICALS INC. RECEIVES $15.3 MILLION IN SERIES A FINANCING ROUND

Funding Supports Clinical Development and Expansion of Therapeutic Platform Targeting Endocannabinoid Pathways

IRVINE, CA – Feb. 9, 2004 – Kadmus Pharmaceuticals Inc., a private biopharmaceutical company developing therapeutics for the treatment of pain, obesity, and other unmet medical needs, today announced that it has received $15.3 million in its Series A financing round, led by Vengrowth Advanced Life Sciences Fund... more>>

GeminX Biotechnologies

July 8, 2008 - Gemin X Pharmaceuticals Appoints Peter R. Dolan to Board of Directors  more>>

June 30, 2008 - Gemin X Pharmaceuticals, Inc. Closes $38 Million Series C Financing to Advance Lead Cancer Drug, Obatoclax, Into Registration Trials more>>

Calypso Medical Technologies

07.27.2008 - Key Prostate Motion Management Experience Using the Calypso® Medical’s 4D Localization System™ To Be Presented at the 50th Annual Meeting of the AAPM more>>

U-Systems

July 2008 - Ron Ho Named President & CEO of U-Systems, Inc.  more>>

Robin Roberts' Breast Cancer Announcement - Early Detection with Ultrasound  more>>

NuGEN Technologies

July 29, 2008 - NuGEN Receives Patent for Global Nucleic Acid Amplification
Unique technology supports new whole genome amplification solutions  more>>

April 23, 2008 - NuGEN Awarded ISO 13485:2003 Medical Devices Certification
Award Affirms Organization’s Commitment to Quality Systems  more>>

Optimer Pharmaceuticals

(8.28.2008) SAN DIEGO, CA - Optimer Pharmaceuticals to Present at BioCentury NewsMakers Conference  more>>

(8.6.2008) SAN DIEGO, CA - Optimer Pharmaceuticals Reports Second Quarter 2008 Financial Results  more>>

geneticXchange

Perlegen Sciences

Perlegen Sciences Out-Licenses Intellectual Property for Genetic Diagnostic - July 15, 2008.  more>>

Perlegen Gains Exclusive Access to Data on Four Million Patients to Enable Personalized Medicine - March 18, 2008.  more>>

Zyomyx

ZYOMYX AWARDED GRANT FROM THE CD4 INITIATIVE AT IMPERIAL COLLEGE LONDON

--Broad manufacturing patents strengthen Invitrogen's position in protein microarrays--

Hayward, Calif. - Mar. 07, 2007 - Zyomyx, Inc., a leader in chip-based bioanalytical technologies, today announced it has been selected by Imperial College London... more>>